ABVD for Hodgkin's lymphoma: full-dose chemotherapy without dose reductions or growth factors
Open Access
- 1 February 2007
- journal article
- Published by Elsevier in Annals of Oncology
- Vol. 18 (2), 376-380
- https://doi.org/10.1093/annonc/mdl397
Abstract
Background: We investigated whether administration of full-dose ABVD (Adriamycin, bleomycin, vinblastine, dacarbazine) chemotherapy without growth factors, and irrespective of the granulocyte count, caused treatment delays or increased the number of infective episodes, in patients with Hodgkin's lymphoma (HL).Keywords
This publication has 25 references indexed in Scilit:
- EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumoursEuropean Journal Of Cancer, 2006
- 2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice GuidelineJournal of Clinical Oncology, 2006
- Neutropenia and febrile neutropenia in patients with Hodgkin's lymphoma treated with doxorubicin (Adriamycin), bleomycin, vinblastine and dacarbazine (ABVD) chemotherapyLeukemia & Lymphoma, 2006
- Bleomycin Pulmonary Toxicity Has a Negative Impact on the Outcome of Patients With Hodgkin's LymphomaJournal of Clinical Oncology, 2005
- Randomized Comparison of ABVD and MOPP/ABV Hybrid for the Treatment of Advanced Hodgkin’s Disease: Report of an Intergroup TrialJournal of Clinical Oncology, 2003
- Secondary Prophylactic G-CSF (Filgrastim) Administration in Chemotherapy of Stage I and II Hodgkin's Lymphoma with ABVDLeukemia & Lymphoma, 2001
- A Prognostic Score for Advanced Hodgkin's DiseaseNew England Journal of Medicine, 1998
- G-CSF (Filgrastim) as an Adjunct to MOPP/ABVD Therapy in Hodgkin's DiseaseActa Oncologica, 1997
- Testicular dysfunction in Hodgkin's disease before and after treatmentEuropean Journal of Cancer and Clinical Oncology, 1991
- Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPPCancer, 1975